Professor Susan Morton and her team of researchers will soon release their latest data from the Growing Up in New Zealand study.
Kia ora, We are embarking on an unprecedented journey over the coming weeks in our duty to keep New Zealand safe. Our priority is the health and welfare of everyone, and that has been our immediate focus as events have unfolded rapidly.
We are in unprecedented times. Right across UniServices, we have been monitoring the situation closely and working on the best possible solutions and outcomes. We are vigilant in our efforts to ensure the safety and wellbeing of our employees, maintain the continuity of our business in an effective manner that upholds our commitments, and adhere to safe practices where our people, our University partners, and our clients and external stakeholders are concerned.
New Zealand’s expertise in maternal and infant health research has led to the University of Auckland’s Liggins Institute and its research transfer company, Auckland UniServices, completing its first clinical trial, the CLIMB study, in collaboration with Chongqing Medical University (CQMU), in South-Western China.
A network of TB researchers across NZ are working with UniServices to create a NZ-wide TB Research Consortium to join with TB Alliance and other global partners to develop future TB drugs.
Funding to connect our top researchers with budding innovators is the latest milestone in the Government’s plan to boost research and development, create more high value jobs and diversify our economy, says Minister of Research, Science and Innovation Megan Woods.
Sensor Holdings Limited has purchased Auckland Bioengineering Institute spin-out StretchSense Limited, of which UniServices was shareholder.
A significant Memorandum of Understanding (MOU) signed in Japan will be of great benefit to New Zealand entrepreneurs and researchers.
UniServices Executive Director Commercialisation Will Charles was awarded the MinterEllisonRuddWatts Commercialisation Professional award at this year's Kiwinet Awards.
Surgical Design Studio (SDS), a provider of innovative products for gastrointestinal diseases, today announces its medical devices have been granted Breakthrough Device designation by the United States Food and Drug Administration (FDA).
Professor Freshwater brings considerable global experience in the higher education sector. Her academic background and leadership will form a foundation for the University's continuing improvement in research and teaching, as well as our social contribution to the wider community.
Twelve outstanding finalists have been selected for the seventh annual KiwiNet Research Commercialisation Awards, designed to celebrate impact from science through successful research commercialisation within New Zealand’s universities, Crown Research Institutes and other research organisations.